The latest study on Immuno-Oncology Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Immuno-Oncology Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Immuno-Oncology and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Hoffmann-La Roche AG
Gilead Sciences Inc.
Incyte
Merck & Co.
EMD Serono
ImmunoCellular Therapeutics
Eli Lilly and Company
Sanofi S.A.
Celldex Therapeutics
Celgene Corporation
Pfizer Inc.
Bavarian Nordic
Bristol-Myers Squibb
AbbVie
Galena Biopharma
AstraZeneca, Plc
Novartis International AG
Aduro BioTech
Amgen, Inc
Johnson & Johnson
Prometheus Therapeutics & Diagnostics
Immuno-Oncology Market Analysis By Type Segment:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Immuno-Oncology Market Analysis By Application Segment:
Hospitals
Pharmacies
Online Pharmacies
The Immuno-Oncology Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Immuno-Oncology Report:
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Immuno-Oncology Market:
Immuno-Oncology market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Immuno-Oncology Market
What is the expected Market size and growth rate of the Immuno-Oncology market for the forecast period
Where is the largest and fastest growing market for Immuno-Oncology market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Immuno-Oncology market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Immuno-Oncology Market status and future forecast.
To present the key Immuno-Oncology Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Immuno-Oncology market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Immuno-Oncology market Which companies are the front runners
What are the major end-use industries of Immuno-Oncology market
Feel free to contact us for Customisation, Request For Free Sample, Ask for discount
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type (2016-2027)
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by Application
1.5.1 Global Immuno-Oncology Market Share by Application (2016-2027)
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immuno-Oncology Market Size
2.2 Immuno-Oncology Growth Trends by Regions
2.2.1 Immuno-Oncology Market Size by Regions (2016-2027)
2.2.2 Immuno-Oncology Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Immuno-Oncology Market Size by Manufacturers
3.1.1 Global Immuno-Oncology Revenue by Manufacturers (2016-2020)
3.1.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2016-2020)
3.1.3 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Immuno-Oncology Key Players Head office and Area Served
3.3 Key Players Immuno-Oncology Product/Solution/Service
3.4 Date of Enter into Immuno-Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Immuno-Oncology Market Size by Type (2016-2020)
4.2 Global Immuno-Oncology Market Size by Application (2016-2020)
5 United States
5.1 United States Immuno-Oncology Market Size (2016-2020)
5.2 Immuno-Oncology Key Players in United States
5.3 United States Immuno-Oncology Market Size by Type
5.4 United States Immuno-Oncology Market Size by Application
6 Europe
6.1 Europe Immuno-Oncology Market Size (2016-2020)
6.2 Immuno-Oncology Key Players in Europe
6.3 Europe Immuno-Oncology Market Size by Type
6.4 Europe Immuno-Oncology Market Size by Application
7 China
7.1 China Immuno-Oncology Market Size (2016-2020)
7.2 Immuno-Oncology Key Players in China
7.3 China Immuno-Oncology Market Size by Type
7.4 China Immuno-Oncology Market Size by Application
8 Japan
8.1 Japan Immuno-Oncology Market Size (2016-2020)
8.2 Immuno-Oncology Key Players in Japan
8.3 Japan Immuno-Oncology Market Size by Type
8.4 Japan Immuno-Oncology Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Immuno-Oncology Market Size (2016-2020)
9.2 Immuno-Oncology Key Players in Southeast Asia
9.3 Southeast Asia Immuno-Oncology Market Size by Type
9.4 Southeast Asia Immuno-Oncology Market Size by Application
10 India
10.1 India Immuno-Oncology Market Size (2016-2020)
10.2 Immuno-Oncology Key Players in India
10.3 India Immuno-Oncology Market Size by Type
10.4 India Immuno-Oncology Market Size by Application
11 Central & South America
11.1 Central & South America Immuno-Oncology Market Size (2016-2020)
11.2 Immuno-Oncology Key Players in Central & South America
11.3 Central & South America Immuno-Oncology Market Size by Type
11.4 Central & South America Immuno-Oncology Market Size by Application
12 International Players Profiles
12.1 Amgen, Inc
12.1.1 Amgen, Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immuno-Oncology Introduction
12.1.4 Amgen, Inc Revenue in Immuno-Oncology Business (2016-2020)
12.1.5 Amgen, Inc Recent Development
12.2 AstraZeneca, Plc
12.2.1 AstraZeneca, Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immuno-Oncology Introduction
12.2.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2016-2020)
12.2.5 AstraZeneca, Plc Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immuno-Oncology Introduction
12.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2016-2020)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immuno-Oncology Introduction
12.4.4 Celgene Corporation Revenue in Immuno-Oncology Business (2016-2020)
12.4.5 Celgene Corporation Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immuno-Oncology Introduction
12.5.4 Eli Lilly and Company Revenue in Immuno-Oncology Business (2016-2020)
12.5.5 Eli Lilly and Company Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immuno-Oncology Introduction
12.6.4 Merck & Co. Revenue in Immuno-Oncology Business (2016-2020)
12.6.5 Merck & Co. Recent Development
12.7 Hoffmann-La Roche AG
12.7.1 Hoffmann-La Roche AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immuno-Oncology Introduction
12.7.4 Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2016-2020)
12.7.5 Hoffmann-La Roche AG Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immuno-Oncology Introduction
12.8.4 Johnson & Johnson Revenue in Immuno-Oncology Business (2016-2020)
12.8.5 Johnson & Johnson Recent Development
12.9 Novartis International AG
12.9.1 Novartis International AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immuno-Oncology Introduction
12.9.4 Novartis International AG Revenue in Immuno-Oncology Business (2016-2020)
12.9.5 Novartis International AG Recent Development
12.10 AbbVie
12.10.1 AbbVie Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immuno-Oncology Introduction
12.10.4 AbbVie Revenue in Immuno-Oncology Business (2016-2020)
12.10.5 AbbVie Recent Development
12.11 Pfizer Inc.
12.12 Sanofi S.A.
12.13 EMD Serono
12.14 Gilead Sciences Inc.
12.15 Prometheus Therapeutics & Diagnostics
12.16 Aduro BioTech
12.17 Galena Biopharma
12.18 Bavarian Nordic
12.19 Celldex Therapeutics
12.20 ImmunoCellular Therapeutics
12.21 Incyte
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Table Immuno-Oncology Key Market Segments
Table Key Players Immuno-Oncology Covered
Table Global Immuno-Oncology Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Immuno-Oncology Market Size Market Share by Type 2016-2027
Figure Immune Checkpoint Inhibitors Figures
Table Key Players of Immune Checkpoint Inhibitors
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Cytokine-Based Immunotherapy Figures
Table Key Players of Cytokine-Based Immunotherapy
Figure Cancer Vaccines Figures
Table Key Players of Cancer Vaccines
Figure CAR-T Cell Therapy Figures
Table Key Players of CAR-T Cell Therapy
Table Global Immuno-Oncology Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Immuno-Oncology Report Years Considered
Table Global Immuno-Oncology Market Size 2016-2027 (Million US$)
Figure Global Immuno-Oncology Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Immuno-Oncology Market Size by Regions 2016-2027 (Million US$)
Table Global Immuno-Oncology Market Size by Regions 2016-2020 (Million US$)
Table Global Immuno-Oncology Market Share by Regions 2016-2020
Figure Global Immuno-Oncology Market Share by Regions 2016-2020
Figure Global Immuno-Oncology Market Share by Regions 2020
Table Market Top Trends
Table Global Immuno-Oncology Revenue by Manufacturers (2016-2020) (Million US$)
Table Global Immuno-Oncology Market Share by Manufacturers (2016-2020)
Figure Global Immuno-Oncology Market Share by Manufacturers in 2020
Table Global Immuno-Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immuno-Oncology Product/Solution/Service
Table Date of Enter into Immuno-Oncology Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table Global Immuno-Oncology Market Size Share by Type (2016-2020)
Figure Global Immuno-Oncology Market Size Market Share by Type (2016-2020)
Table Global Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table Global Immuno-Oncology Market Size Share by Application (2016-2020)
Figure Global Immuno-Oncology Market Size Market Share by Application (2016-2020)
Figure Global Immuno-Oncology Revenue Market Share by Application in 2020
Figure United States Immuno-Oncology Market Size 2016-2020 (Million US$)
Table United States Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table United States Key Players Immuno-Oncology Market Share (2020-2020)
Table United States Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table United States Immuno-Oncology Market Share by Type (2016-2020)
Table United States Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table United States Immuno-Oncology Market Share by Application (2016-2020)
Figure Europe Immuno-Oncology Market Size 2016-2020 (Million US$)
Table Europe Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table Europe Key Players Immuno-Oncology Market Share (2020-2020)
Table Europe Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table Europe Immuno-Oncology Market Share by Type (2016-2020)
Table Europe Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table Europe Immuno-Oncology Market Share by Application (2016-2020)
Figure China Immuno-Oncology Market Size 2016-2020 (Million US$)
Table China Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table China Key Players Immuno-Oncology Market Share (2020-2020)
Table China Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table China Immuno-Oncology Market Share by Type (2016-2020)
Table China Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table China Immuno-Oncology Market Share by Application (2016-2020)
Figure Japan Immuno-Oncology Market Size 2016-2020 (Million US$)
Table Japan Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table Japan Key Players Immuno-Oncology Market Share (2020-2020)
Table Japan Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table Japan Immuno-Oncology Market Share by Type (2016-2020)
Table Japan Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table Japan Immuno-Oncology Market Share by Application (2016-2020)
Figure Southeast Asia Immuno-Oncology Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table Southeast Asia Key Players Immuno-Oncology Market Share (2020-2020)
Table Southeast Asia Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Immuno-Oncology Market Share by Type (2016-2020)
Table Southeast Asia Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Immuno-Oncology Market Share by Application (2016-2020)
Figure India Immuno-Oncology Market Size 2016-2020 (Million US$)
Table India Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table India Key Players Immuno-Oncology Market Share (2020-2020)
Table India Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table India Immuno-Oncology Market Share by Type (2016-2020)
Table India Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table India Immuno-Oncology Market Share by Application (2016-2020)
Figure Central & South America Immuno-Oncology Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Immuno-Oncology Revenue (2020-2020) (Million US$)
Table Central & South America Key Players Immuno-Oncology Market Share (2020-2020)
Table Central & South America Immuno-Oncology Market Size by Type (2016-2020) (Million US$)
Table Central & South America Immuno-Oncology Market Share by Type (2016-2020)
Table Central & South America Immuno-Oncology Market Size by Application (2016-2020) (Million US$)
Table Central & South America Immuno-Oncology Market Share by Application (2016-2020)
Table Amgen, Inc Company Details
Table Amgen, Inc Revenue in Immuno-Oncology Business (2016-2020) (Million US$)
Figure Amgen, Inc Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Amgen, Inc Recent Development
Table AstraZeneca, Plc Company Details
Table AstraZeneca, Plc Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table AstraZeneca, Plc Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Celgene Corporation Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Eli Lilly and Company Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Merck & Co. Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Merck & Co. Recent Development
Table Hoffmann-La Roche AG Company Details
Table Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Hoffmann-La Roche AG Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure Novartis International AG Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table Novartis International AG Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Immuno-Oncology Business (2016-2020)(Million US$)
Figure AbbVie Revenue Growth Rate in Immuno-Oncology Business (2016-2020)
Table AbbVie Recent Development
Table Pfizer Inc. Company Details
Table Sanofi S.A. Company Details
Table EMD Serono Company Details
Table Gilead Sciences Inc. Company Details
Table Prometheus Therapeutics & Diagnostics Company Details
Table Aduro BioTech Company Details
Table Galena Biopharma Company Details
Table Bavarian Nordic Company Details
Table Celldex Therapeutics Company Details
Table ImmunoCellular Therapeutics Company Details
Table Incyte Company Details
Table Global Immuno-Oncology Market Size by Regions (Million US$) 2021-2027
Figure Global Immuno-Oncology Market Size Share by Regions (2021-2027)
Figure Global Immuno-Oncology Market Size Share by Regions in 2027
Figure United States Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Europe Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Figure China Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Japan Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Figure India Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Immuno-Oncology Market Size Forecast (2021-2027)(Million USD)
Table Global Immuno-Oncology Market Size by Product (2021-2027) (Million US$)
Figure Global Immuno-Oncology Market Size by Product (2021-2027)
Figure Global Immuno-Oncology Market Size by Product in 2027
Table Global Immuno-Oncology Market Size by Application (2021-2027) (Million US$)
Figure Global Immuno-Oncology Market Size by Application (2021-2027)
Figure Global Immuno-Oncology Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources